WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on 1 APRIL 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • IFSIJ Measure of Journal Quality
  • Scientific Journal Impact Factor (SJIF)
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database

Abstract

A CLINICAL STUDY ON THE EFFECT OF VASADI KWATHA AND ELADI GUTIKA IN THE MANAGEMENT OF SWARABHEDA W.S.R. TO HOARSENESS OF VOICE

Dr. Manu Priya*, Dr. Vijayant Bhardwaj, Dr. Satish Sharma, Dr. Pooja Devi and Dr. Muhsinath K. P.

ABSTRACT

With an evolutionary history that spans several thousands of years, Ayurveda is one of the oldest and meticulously codified systems of healthcare in the world.[1] The vitiated doshas circulating in the body, with predominance of vitiated Vata & Kapha migrate to Mukha Pradesha, thus causes the Mukha rogas. When they get located (Sthana sanshraya) in the kantha Pradesha, Swarabheda occurs. Swarabheda can be correlated with Hoarseness of Voice as both of them have similar features. This study included detailed study of the disease, its nature and the evaluation of the effects of the two formulations- Vasadi Kwatha mentioned by Acharya Sharangdhara and Eladi Gutika of Acharya Charaka.18 patients fulfilling the inclusion criteria were included in this trial into one single group and were given Vasadi Kwatha (40ml in two divided doses) and Eladi Gutika (12gm in divided doses in the form of chewable pills) for two weeks. The effect of therapy was assessed by grading and scoring system based on signs and symptoms. Out of 18 patients, 12 patients were completely cured, 4 patients were markedly improved and 2 patients were moderately improved.

[Full Text Article] [Download Certificate]